Clinical Trial Update: An Open-Label Study of Intra-articular AMB-05X Injections in Subjects With Tenosynovial Giant Cell Tumor of the Knee [Phase 2]

View source ↗

Summary

A Phase 2 open-label study evaluating intra-articular AMB-05X injections for knee Tenosynovial Giant Cell Tumor/Pigmented Villonodular Synovitis has completed a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pigmented Villonodular Synovitis
• Tenosynovial Giant Cell Tumor

Drugs mentioned

• AMB-05X

Snippet

Sponsor: AmMax Bio, Inc. | Conditions: Tenosynovial Giant Cell Tumor, Pigmented Villonodular Synovitis (PVNS) | Phase 2 | Status: COMPLETED | Results posted: 2024-06-27